These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-alcoholic steatohepatitis in children. Nanda K. Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [Abstract] [Full Text] [Related]
3. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. McCullough AJ. Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061 [Abstract] [Full Text] [Related]
10. Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH). Yamagishi S, Nakamura K, Inoue H. Med Hypotheses; 2005 Jun; 65(2):377-9. PubMed ID: 15922116 [Abstract] [Full Text] [Related]
12. Non-alcoholic steatohepatitis. Das K, Kar P. J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603 [Abstract] [Full Text] [Related]
13. [Nonalcoholic steatohepatitis: pathogenesis and treatment]. Park SH. Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854 [Abstract] [Full Text] [Related]
14. The emerging problem of nonalcoholic steatohepatitis (NASH). Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693 [Abstract] [Full Text] [Related]
15. The treatment of NAFLD. Trappoliere M, Tuccillo C, Federico A, Di Leva A, Niosi M, D'Alessio C, Capasso R, Coppola F, Dauria M, Loguercio C. Eur Rev Med Pharmacol Sci; 2005 Mar; 9(5):299-304. PubMed ID: 16231594 [Abstract] [Full Text] [Related]
16. Nonalcoholic steatohepatitis: what we know in the new millennium. Harrison SA, Kadakia S, Lang KA, Schenker S. Am J Gastroenterol; 2002 Nov; 97(11):2714-24. PubMed ID: 12425538 [Abstract] [Full Text] [Related]
17. [Diagnosis and therapy in NASH]. Tokushige K. Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210 [Abstract] [Full Text] [Related]
19. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL. Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454 [Abstract] [Full Text] [Related]
20. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC. Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [Abstract] [Full Text] [Related] Page: [Next] [New Search]